The second panel discussion took place on April 22, 2024, on the topic The Perspective of Clinical Trials in Croatia. In collaboration with LabSense, a lecture was held at BioCentar regarding the efficiency of conducting clinical trials in Croatia.
The unique professional experience of Antonija Benete from LabSense and Josipa Ljubičić from Proqlea elevated the discussion on this topic to a higher level. The experts were unanimous; a Clinical Trial Hub can make a difference in trials and have a significant impact on Croatia’s GDP.
Following the lecture, a panel discussion was held on the current state and future of clinical trials in Croatia.
Participants included:
- Zlatica Bojadzieska, MPharm, Deputy Director of the R&D Clinical Unit at ALKALOID AD Skopje,
- Dr. Vlatka Vrdoljak, Head of Clinical Trial Processes (Development Medicine and Vigilance at JGL),
- Mitja Posavec, MPharm, Director of Business Development and Regulatory Affairs at Belupo,
- Jan Štimac, MPharm, Director of Quality Assurance at Sandoz,
- Maja Radulović, MPharm, Clinical Pharmacy Specialist at KBC Zagreb, along with
- Prof. Vladimir Trkulja, Clinical Pharmacologist and Professor at the Medical Faculty of the University of Zagreb..
